A383930 Share Price Performance
₩2,760.00
-4420.00 (-61.56%)
Price ₩2,760.00
Share Pricen/a
Benign Growth For DT&CRO CO., Ltd. (KOSDAQ:383930) Underpins Stock's 25% Plummet
Dec 30
DT&CRO CO., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A383930 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
DT&CRO CO., Ltd. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- 326.46
- 1.96%
- 9.41%
- 137.6%
About A383930
- Founded
- 2017
- Employees
- n/a
- CEO
- WebsiteView website
DT&CRO CO., Ltd. operates as a full-service CRO provider in South Korea. The company conducts a series of consigned studies ranging from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics, and medical devices to analysis, bioactivity, clinical trials, and licensing consulting. DT&CRO CO., Ltd. was founded in 2017 and is based in Yongin, South Korea.
